A detailed history of Pro Share Advisors LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,859 shares of CRMD stock, worth $218,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,859
Previous 19,947 20.49%
Holding current value
$218,695
Previous $161,000 39.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

SELL
$6.16 - $12.57 $25,182 - $51,386
-4,088 Reduced 20.49%
15,859 $97,000
Q4 2024

Feb 13, 2025

BUY
$8.1 - $13.59 $77,500 - $130,029
9,568 Added 92.19%
19,947 $161,000
Q3 2024

Nov 13, 2024

BUY
$3.64 - $8.23 $37,779 - $85,419
10,379 New
10,379 $83,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $568M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.